Young Ho Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young Ho Yang has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Ha Eun Kim
Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea
10 shared publications - Jin Gu Lee
Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea
8 shared publications - Chang Young Lee
Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea
7 shared publications - Dae Joon Kim
Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea
5 shared publications - Byung Jo Park
Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea
4 shared publications - Moo Suk Park
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
4 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Importance of psychiatric evaluation and long-term outcomes of delirium in lung transplant recipients
Psychiatric conditions, specifically anxiety and depression, are common among patients with end-stage lung disease [1–4]. These conditions are often exacerbated by the physical burden of the diseas...
- 3 August 2026
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1)
Open AccessImportance of psychiatric evaluation and long-term outcomes of delirium in lung transplant recipients
Psychiatric conditions, specifically anxiety and depression, are common among patients with end-stage lung disease [1–4]. These conditions are often exacerbated by the physical burden of the diseas...
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (4) , 334-340
Effect of Donor Lung Resection Technique on Bronchopleural Fistula in Transplantation: Pulmonary Tailoring Versus Hilar Dissection
Yang YH, et al. Yonsei Med J. 2026 ;67:e12. https://doi.org/10.3349/ymj.2025.0153
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (4) , 334-340
Open AccessEffect of Donor Lung Resection Technique on Bronchopleural Fistula in Transplantation: Pulmonary Tailoring Versus Hilar Dissection
Yang YH, et al. Yonsei Med J. 2026 ;67:e12. https://doi.org/10.3349/ymj.2025.0153
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (1) , 27-33
Outcomes of Lung Transplantation for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation Compared with Those for Idiopathic Pulmonary Fibrosis
Park BS, et al. Yonsei Med J. 2026 Jan;67(1):27-33. https://doi.org/10.3349/ymj.2024.0475
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (1) , 27-33
Open AccessOutcomes of Lung Transplantation for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation Compared with Those for Idiopathic Pulmonary Fibrosis
Park BS, et al. Yonsei Med J. 2026 Jan;67(1):27-33. https://doi.org/10.3349/ymj.2024.0475
- Open Access
- 13 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (9) , 927
Clinical Characteristics, Outcomes, and Distribution Patterns of Pathogens Causing Respiratory Infections in Lung Retransplant Recipients
Introduction: With advances in surgical techniques and immunosuppressive therapies, lung retransplantation has become a viable option for patients experiencing graft failure. However, retransplantation is associated with inferior clinical outcomes, and infection remains a leading cause of morbidity and mortality in lung retransplant recipients. Objectives: This study examined clinical characteristics, outcomes, and microbial spectra of respiratory infections in lung retransplant recipients. Methods: This retrospective case–control study, conducted at two tertiary care centers, included 10 lung retransplant patients and 20 matched primary lung transplant patients. Respiratory pathogens identified using bronchoalveolar lavage (BAL) were compared between two groups over a two-year post-transplantation period. Results: Pulmonary hypertension was more prevalent in the retransplant group (p = 0.030). Five-year mortality and infection-related mortality were higher in the retransplant group (both p = 0.015), along with longer hospital and intensive care unit stays (p = 0.035 and 0.017, respectively). BAL cultures revealed distinct temporal patterns: Elizabethkingia predominated early (31.6% within 1 month) in the retransplant group, with Pseudomonas increasing gradually. The primary transplant group demonstrated a more heterogeneous distribution, with Acinetobacter, Pseudomonas, and Enterococcus detected early. Conclusions: Retransplant recipients exhibited worse clinical outcomes and a distinct temporal distribution of respiratory pathogens. Particularly, the high incidence of Elizabethkingia in lung retransplant recipients highlights the need for center-specific infection surveillance and tailored preventive strategies to improve retransplantation outcomes.
- 13 September 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (9) , 927
Open AccessClinical Characteristics, Outcomes, and Distribution Patterns of Pathogens Causing Respiratory Infections in Lung Retransplant Recipients
Introduction: With advances in surgical techniques and immunosuppressive therapies, lung retransplantation has become a viable option for patients experiencing graft failure. However, retransplantation is associated with inferior clinical outcomes, and infection remains a leading cause of morbidity and mortality in lung retransplant recipients. Objectives: This study examined clinical characteristics, outcomes, and microbial spectra of respiratory infections in lung retransplant recipients. Methods: This retrospective case–control study, conducted at two tertiary care centers, included 10 lung retransplant patients and 20 matched primary lung transplant patients. Respiratory pathogens identified using bronchoalveolar lavage (BAL) were compared between two groups over a two-year post-transplantation period. Results: Pulmonary hypertension was more prevalent in the retransplant group (p = 0.030). Five-year mortality and infection-related mortality were higher in the retransplant group (both p = 0.015), along with longer hospital and intensive care unit stays (p = 0.035 and 0.017, respectively). BAL cultures revealed distinct temporal patterns: Elizabethkingia predominated early (31.6% within 1 month) in the retransplant group, with Pseudomonas increasing gradually. The primary transplant group demonstrated a more heterogeneous distribution, with Acinetobacter, Pseudomonas, and Enterococcus detected early. Conclusions: Retransplant recipients exhibited worse clinical outcomes and a distinct temporal distribution of respiratory pathogens. Particularly, the high incidence of Elizabethkingia in lung retransplant recipients highlights the need for center-specific infection surveillance and tailored preventive strategies to improve retransplantation outcomes.
- Open Access
- 31 December 2024
- Published by Korean Society of Neuroimmunology in Journal of Multiple Sclerosis and Neuroimmunology
- Vol. 15 (2) , 72-80
Temporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis
Background: This study investigates the potential link between myasthenia gravis (MG) exacerbation and thymoma recurrence in patients with thymoma-associated MG (TAMG).Methods: We conducted a retrospective medical record analysis at Severance Hospital. Baseline clinical feature of MG, initial histological features, and severity of MG were recorded. Based on the change in MG activities of daily living (ADL) score and MG-spsecific treatments, patients' MG status was assessed over the 2-year period around thymoma recurrence, and was classified into three categories: improved, unchanged, and worse.Results: Of the 178 patients with TAMG, 18 (10.1%) experienced recurrence of thymoma. Mean age at initial thymectomy and at thymoma recurrence was 44.1±9.4 and 48.8±9.1 years, respectively. At the point of thymoma recurrence, myasthenia gravis foundation of America post-intervention status was complete stable remission in four (22.2%), pharmacologic remission in five (27.8%), minimal manifestation in five (27.8%), improved in two (11.1%), and unchanged in two (11.1%) patients. Median MG ADL score was 0.0 (interquartile range [Q1-Q3], 0.0-1.8). During 1-year period before recurrence of thymoma, three patients experienced worsening, probably associated with infection and discontinuation of medication. During the 1-year period after the recurrence, four patients experienced worsening after the second thymectomy.Conclusion: MG worsened in 16.7% and 22.2% of the patients before and after thymoma recurrence, respectively. Exacerbation of MG in cases of thymoma recurrence seems more likely to result from known risk factors, including infection, general anesthesia, or discontinuation of medication, rather than from the recurrence of thymoma itself.
- 31 December 2024
- Published by Korean Society of Neuroimmunology in Journal of Multiple Sclerosis and Neuroimmunology
- Vol. 15 (2) , 72-80
Open AccessTemporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis
Background: This study investigates the potential link between myasthenia gravis (MG) exacerbation and thymoma recurrence in patients with thymoma-associated MG (TAMG).Methods: We conducted a retrospective medical record analysis at Severance Hospital. Baseline clinical feature of MG, initial histological features, and severity of MG were recorded. Based on the change in MG activities of daily living (ADL) score and MG-spsecific treatments, patients' MG status was assessed over the 2-year period around thymoma recurrence, and was classified into three categories: improved, unchanged, and worse.Results: Of the 178 patients with TAMG, 18 (10.1%) experienced recurrence of thymoma. Mean age at initial thymectomy and at thymoma recurrence was 44.1±9.4 and 48.8±9.1 years, respectively. At the point of thymoma recurrence, myasthenia gravis foundation of America post-intervention status was complete stable remission in four (22.2%), pharmacologic remission in five (27.8%), minimal manifestation in five (27.8%), improved in two (11.1%), and unchanged in two (11.1%) patients. Median MG ADL score was 0.0 (interquartile range [Q1-Q3], 0.0-1.8). During 1-year period before recurrence of thymoma, three patients experienced worsening, probably associated with infection and discontinuation of medication. During the 1-year period after the recurrence, four patients experienced worsening after the second thymectomy.Conclusion: MG worsened in 16.7% and 22.2% of the patients before and after thymoma recurrence, respectively. Exacerbation of MG in cases of thymoma recurrence seems more likely to result from known risk factors, including infection, general anesthesia, or discontinuation of medication, rather than from the recurrence of thymoma itself.
- Open Access
Stereotypic T cell receptor clonotypes in the thymus and peripheral blood of Myasthenia gravis patients
- 27 November 2022
- Published by Springer Nature
- p. 13-22
Surgical Planning and the Division of the Intersegmental Plane During Thoracoscopic Segmentectomy
- 27 November 2022
- Published by Springer Nature
- p. 13-22
Surgical Planning and the Division of the Intersegmental Plane During Thoracoscopic Segmentectomy
- Open Access
- 7 November 2022
- Published by Wiley in Thoracic Cancer
- Vol. 13 (23) , 3310-3321
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
Background: The prognosis of invasive mucinous adenocarcinoma (IMA) remains controversial and should be clarified by comparison with the International Association for the Study of Lung Cancer (IASLC) histologic grading system for invasive nonmucinous adenocarcinoma (INMA).Methods: This study included patients with IMA who underwent curative resection. Their clinicopathological outcomes were compared with those of patients with INMA. Propensity score matching was performed to compare the prognosis of IMA with IASLC grade 2 or 3. Kaplan–Meier survival curves and log‐rank tests were used to analyze recurrence‐free survival (RFS) and overall survival (OS).Results: The prognoses of IMA and IASLC grade 2 were similar in terms of RFS and OS. Although patients with IMA had better RFS than patients with IASLC grade 3, the OS was not significantly different. After propensity score matching, IMA demonstrated similar RFS to IASLC grade 2 but superior to IASLC grade 3; there was no difference in the OS compared with grades 2/3. Multivariate analysis revealed that tumor size (hazard ratio [HR] = 1.20, p = 0.028), lymphovascular invasion (HR = 127.5, p = 0.003), and maximum standardized uptake value (HR = 1.24, p = 0.005) were poor prognostic predictors for RFS. Patients with IMA demonstrated RFS similar to and significantly better than that of patients with IASLC grades 2 and 3, respectively. For OS, IMA prognosis was between that of IASLC grades 2 and 3.Conclusions: Since the prognosis of IMA among lung adenocarcinomas appears to be relatively worse, further clinical studies investigating IMA‐specific treatment and follow‐up plans are necessary to draw more inferences.
- 7 November 2022
- Published by Wiley in Thoracic Cancer
- Vol. 13 (23) , 3310-3321
Open AccessPrognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
Background: The prognosis of invasive mucinous adenocarcinoma (IMA) remains controversial and should be clarified by comparison with the International Association for the Study of Lung Cancer (IASLC) histologic grading system for invasive nonmucinous adenocarcinoma (INMA).Methods: This study included patients with IMA who underwent curative resection. Their clinicopathological outcomes were compared with those of patients with INMA. Propensity score matching was performed to compare the prognosis of IMA with IASLC grade 2 or 3. Kaplan–Meier survival curves and log‐rank tests were used to analyze recurrence‐free survival (RFS) and overall survival (OS).Results: The prognoses of IMA and IASLC grade 2 were similar in terms of RFS and OS. Although patients with IMA had better RFS than patients with IASLC grade 3, the OS was not significantly different. After propensity score matching, IMA demonstrated similar RFS to IASLC grade 2 but superior to IASLC grade 3; there was no difference in the OS compared with grades 2/3. Multivariate analysis revealed that tumor size (hazard ratio [HR] = 1.20, p = 0.028), lymphovascular invasion (HR = 127.5, p = 0.003), and maximum standardized uptake value (HR = 1.24, p = 0.005) were poor prognostic predictors for RFS. Patients with IMA demonstrated RFS similar to and significantly better than that of patients with IASLC grades 2 and 3, respectively. For OS, IMA prognosis was between that of IASLC grades 2 and 3.Conclusions: Since the prognosis of IMA among lung adenocarcinomas appears to be relatively worse, further clinical studies investigating IMA‐specific treatment and follow‐up plans are necessary to draw more inferences.
- Open Access
- 7 April 2022
- Published by Wiley in Thoracic Cancer
- Vol. 13 (9) , 1401-1405
Postoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its success
Background: The purpose of this study was to investigate the results of postoperative bronchopleural fistula repair and to identify adverse factors for its success.Methods: We retrospectively reviewed the surgical results of 39 patients who underwent surgical repair for postoperative bronchopleural fistula between January 2010 and June 2020. Success of bronchopleural fistula repair was defined as the visual closure of the bronchopleural fistula with the absence of an air leak, a recurrence of bronchopleural fistula and infection in the thoracic cavity.Results: Twenty‐five (64.1%) bronchopleural fistulas occurred after pulmonary resection and 14 (35.9%) after lung transplantation. Bronchopleural fistula was diagnosed 19 days (median) and repaired 28 days (median) after the initial operation by primary closure in 27 (69.2%) patients, and by additional resection in 12 (30.8%) patients. The overall success rate was 59% (23/39) and the overall mortality was 56.4% (22/39). Multivariable analysis revealed that the patients who were supported by mechanical ventilation at the time of repair had significantly lower success rates than those without (15.4%, 2/13 vs. 80.8%, 21/26, respectively, p < 0.001). The omental flap group tended to have a better success rate than the muscle flap group (p = 0.07).Conclusions: There was a high overall mortality rate after bronchopleural fistula repair and a low success rate. Mechanical ventilation at the time of bronchopleural fistula repair was significantly related to the failure of bronchopleural fistula repair.
- 7 April 2022
- Published by Wiley in Thoracic Cancer
- Vol. 13 (9) , 1401-1405
Open AccessPostoperative bronchopleural fistula repair: Surgical outcomes and adverse factors for its success
Background: The purpose of this study was to investigate the results of postoperative bronchopleural fistula repair and to identify adverse factors for its success.Methods: We retrospectively reviewed the surgical results of 39 patients who underwent surgical repair for postoperative bronchopleural fistula between January 2010 and June 2020. Success of bronchopleural fistula repair was defined as the visual closure of the bronchopleural fistula with the absence of an air leak, a recurrence of bronchopleural fistula and infection in the thoracic cavity.Results: Twenty‐five (64.1%) bronchopleural fistulas occurred after pulmonary resection and 14 (35.9%) after lung transplantation. Bronchopleural fistula was diagnosed 19 days (median) and repaired 28 days (median) after the initial operation by primary closure in 27 (69.2%) patients, and by additional resection in 12 (30.8%) patients. The overall success rate was 59% (23/39) and the overall mortality was 56.4% (22/39). Multivariable analysis revealed that the patients who were supported by mechanical ventilation at the time of repair had significantly lower success rates than those without (15.4%, 2/13 vs. 80.8%, 21/26, respectively, p < 0.001). The omental flap group tended to have a better success rate than the muscle flap group (p = 0.07).Conclusions: There was a high overall mortality rate after bronchopleural fistula repair and a low success rate. Mechanical ventilation at the time of bronchopleural fistula repair was significantly related to the failure of bronchopleural fistula repair.